Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.78 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.51 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17813120 | 0.93 | MAPT (0.69) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL25502467 | 0.89 | CHRM2 (0.82) | CHRM2ADORA3KCNH2MAPTLMNA | |
| Oxyphenisatine SCHEMBL35387956 | 0.88 | CHRM2 (1.00) | CHRM2ADORA3KCNH2MAPTLMNA | |
| Oxyphenisatine SCHEMBL239513 | 0.88 | CHRM2 (1.00) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL13145362 | 0.86 | CHRM2 (0.78) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL11748640 | 0.86 | CHRM2 (0.78) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL2716060 | 0.85 | CHRM2 (0.93) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL5478595 | 0.84 | CHRM2 (0.57) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL5485508 | 0.84 | CHRM2 (0.57) | CHRM2ADORA3KCNH2MAPTLMNA | |
| SCHEMBL7031893 | 0.84 | CHRM2 (0.85) | CHRM2ADORA3KCNH2MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130200415-A1 | LIGHT EMITTING DIODE DEVICE AND METHOD FOR PRODUCTION THEREOF CONTAINING CONVERSION MATERIAL CHEMISTRY | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-08-08 | — | — | US | disclosed |
| US-8461249-B2 | Compositions and articles of manufacture containing branched polycarbonate | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-06-11 | — | — | US | disclosed |
| US-20100029646-A1 | PRODRUGS OF DIPHENYL OX-INDOL-2-ONE COMPOUNDS | TOPO TARGET A/S (DK) | 2010-02-04 | — | — | US | disclosed |
| US-20100029646-A1 | PRODRUGS OF DIPHENYL OX-INDOL-2-ONE COMPOUNDS | TOPO TARGET A/S (DK) | 2010-02-04 | — | — | US | disclosed |
| US-20100029646-A1 | PRODRUGS OF DIPHENYL OX-INDOL-2-ONE COMPOUNDS | TOPO TARGET A/S (DK) | 2010-02-04 | — | — | US | disclosed |
| EP-2102158-A1 | PRODRUGS OF DIPHENYL OX- INDOL- 2 -ONE COMPOUNDS FOR THE TREATMENT OF CANCERS | Topo Target A/S (DK) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008071387-A1 | PRODRUGS OF DIPHENYL OX- INDOL- 2 -ONE COMPOUNDS FOR THE TREATMENT OF CANCERS | TOPOTARGET A/S (DK) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008071387-A1 | PRODRUGS OF DIPHENYL OX- INDOL- 2 -ONE COMPOUNDS FOR THE TREATMENT OF CANCERS | TOPOTARGET A/S (DK) | 2008-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029646-A1 | PRODRUGS OF DIPHENYL OX-INDOL-2-ONE COMPOUNDS | IDO1, IDO2, TDO2 | CHRM2 2494/4885ADORA3 586/4885KCNH2 3560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.